Dr. Michael D Kaufman

MD | Neurology


  1350 S Kings Dr, Charlotte
     North Carolina, 28207-2134
  704-446-1242    704-446-1241 Maps & Directions
Dr. Michael D Kaufman is a Charlotte, North Carolina based neurologist who is specialized in Neurology. His current practice location is 1350 S Kings Dr, Charlotte. Patients can reach him at 704-446-1242 or can fax him at 704-446-1241. Dr. Michael D Kaufman is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1053336628.
Dr. Michael D Kaufman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Michael D Kaufman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Michael D Kaufman
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:1350 S Kings Dr, Charlotte,
North Carolina, 28207-2134
Phone:704-446-1242
Fax:704-446-1241
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1053336628
NPI Enumeration Date: 13 Jul, 2006
NPI Last Update On: 05 Jun, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Michael D Kaufman
Po Box 601372,
Charlotte, North Carolina
Zip: 28260-1372
Phone Number: 704-446-1242
Fax Number: 704-446-1241
Patients can reach Dr. Michael D Kaufman at 1350 S Kings Dr, Charlotte, North Carolina or can call to book an appointment on 704-446-1242.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.